LifeStance Health Group (NASDAQ:LFST) Earns Buy Rating from Analysts at BTIG Research

BTIG Research initiated coverage on shares of LifeStance Health Group (NASDAQ:LFST) in a research note released on Friday, MarketBeat.com reports. The brokerage issued a buy rating and a $8.00 target price on the stock.

A number of other research analysts have also recently weighed in on the stock. UBS Group raised shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $8.50 price objective for the company in a research note on Tuesday, May 27th. KeyCorp began coverage on shares of LifeStance Health Group in a research note on Tuesday, April 8th. They set an “overweight” rating and a $9.00 price objective for the company. Finally, Canaccord Genuity Group began coverage on shares of LifeStance Health Group in a research note on Thursday, April 3rd. They set a “buy” rating and a $8.00 price objective for the company. One analyst has rated the stock with a sell rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $8.42.

LifeStance Health Group Stock Performance

NASDAQ LFST opened at $4.14 on Friday. LifeStance Health Group has a 52-week low of $4.09 and a 52-week high of $8.61. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 0.19. The stock has a market capitalization of $1.61 billion, a P/E ratio of -41.40 and a beta of 1.16. The firm has a 50-day moving average price of $5.13 and a 200 day moving average price of $6.44.

Insider Transactions at LifeStance Health Group

In related news, insider Ujjwal Ramtekkar sold 16,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 5th. The shares were sold at an average price of $5.94, for a total transaction of $95,040.00. Following the sale, the insider owned 113,435 shares in the company, valued at approximately $673,803.90. This trade represents a 12.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 6.60% of the company’s stock.

Institutional Trading of LifeStance Health Group

A number of hedge funds have recently bought and sold shares of LFST. Blair William & Co. IL acquired a new position in shares of LifeStance Health Group in the 2nd quarter valued at $70,000. Public Employees Retirement System of Ohio acquired a new position in shares of LifeStance Health Group in the 2nd quarter valued at $70,000. Park Edge Advisors LLC acquired a new position in shares of LifeStance Health Group in the 2nd quarter valued at $52,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of LifeStance Health Group by 1.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 615,652 shares of the company’s stock valued at $4,100,000 after purchasing an additional 11,331 shares during the last quarter. Finally, Voleon Capital Management LP acquired a new position in shares of LifeStance Health Group in the 1st quarter valued at $163,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.